Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).

Bibliographic Information

Title
Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
Author
Mizuno N., et. al.
Published
2007
Resource Type
journal article

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1010000781977526657
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top